1. Home
  2. XEL vs ONC Comparison

XEL vs ONC Comparison

Compare XEL & ONC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Energy Inc.

XEL

Xcel Energy Inc.

N/A

Current Price

$81.40

Market Cap

49.2B

Sector

Utilities

ML Signal

N/A

ONC

BeiGene Ltd. American Depositary Shares

N/A

Current Price

$299.97

Market Cap

33.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XEL
ONC
Founded
1909
2010
Country
United States
Switzerland
Employees
N/A
12000
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.2B
33.5B
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
XEL
ONC
Price
$81.40
$299.97
Analyst Decision
Buy
Strong Buy
Analyst Count
14
10
Target Price
$84.36
$386.70
AVG Volume (30 Days)
4.2M
224.8K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
2.78%
N/A
EPS Growth
N/A
N/A
EPS
3.42
N/A
Revenue
$11,537,000,000.00
N/A
Revenue This Year
$9.67
$759.19
Revenue Next Year
$8.02
$14.51
P/E Ratio
$23.97
$614.06
Revenue Growth
N/A
N/A
52 Week Low
$65.21
$196.53
52 Week High
$84.23
$385.22

Technical Indicators

Market Signals
Indicator
XEL
ONC
Relative Strength Index (RSI) 54.49 34.99
Support Level $71.95 $292.79
Resistance Level $82.51 $300.00
Average True Range (ATR) 1.33 9.26
MACD -0.35 -4.29
Stochastic Oscillator 26.58 12.16

Price Performance

Historical Comparison
XEL
ONC

About XEL Xcel Energy Inc.

Xcel Energy manages utilities serving 3.9 million electric customers and 2.2 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan; Public Service Company of Colorado; and Southwestern Public Service Company, which serves customers in Texas and New Mexico. It is one of the largest renewable energy suppliers in the US, with more than half of its electricity sales coming from carbon-free energy.

About ONC BeiGene Ltd. American Depositary Shares

BeOne Medicines Ltd is a holding company. Through its subsidiaries, it operates as an oncology-focused biopharmaceutical company engaged in the discovery and development of treatments for cancer. Its portfolio includes BRUKINSA (a Bruton's tyrosine kinase (BTK) inhibitor), sonrotoclax (a B-cell lymphoma 2 (BCL2) inhibitor, and a BTK chimeric degradation activation compound (BTK-CDAC). The company develops and commercializes wholly owned therapeutic assets targeting multiple mechanisms of action in oncology. The company operates in one segment: pharmaceutical products. It generates the majority of its revenue from the sale of its biopharmaceutical products.

Share on Social Networks: